Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.

Chakrabarti BK, Pancera M, Phogat S, O'Dell S, McKee K, Guenaga J, Robinson J, Mascola J, Wyatt RT.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19.

PMID:
21158699
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency.

Zhang MY, Dimitrov DS.

Curr Pharm Des. 2007;13(2):203-12. Review.

PMID:
17269928
[PubMed - indexed for MEDLINE]
3.

GP120: target for neutralizing HIV-1 antibodies.

Pantophlet R, Burton DR.

Annu Rev Immunol. 2006;24:739-69. Review.

PMID:
16551265
[PubMed - indexed for MEDLINE]
4.

Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

Hrin R, Montgomery DL, Wang F, Condra JH, An Z, Strohl WR, Bianchi E, Pessi A, Joyce JG, Wang YJ.

AIDS Res Hum Retroviruses. 2008 Dec;24(12):1537-44. doi: 10.1089/aid.2008.0129. Review.

PMID:
19102685
[PubMed - indexed for MEDLINE]
5.

Structure-based vaccine design in HIV: blind men and the elephant?

Pejchal R, Wilson IA.

Curr Pharm Des. 2010;16(33):3744-53. Review.

PMID:
21128885
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Neutralizing antibodies to HIV-1 induced by immunization.

McCoy LE, Weiss RA.

J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827. Review.

PMID:
23401570
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.

Pollara J, Bonsignori M, Moody MA, Pazgier M, Haynes BF, Ferrari G.

Curr HIV Res. 2013 Jul;11(5):378-87. Review.

PMID:
24191939
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.

Georgiev IS, Gordon Joyce M, Zhou T, Kwong PD.

Curr Opin HIV AIDS. 2013 Sep;8(5):382-92. doi: 10.1097/COH.0b013e328363a90e. Review.

PMID:
23924998
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.

Chen W, Ying T, Dimitrov DS.

Expert Opin Biol Ther. 2013 May;13(5):657-71. doi: 10.1517/14712598.2013.761969. Epub 2013 Jan 7. Review.

PMID:
23293858
[PubMed - indexed for MEDLINE]
10.

HIV-1 envelope glycoprotein structure.

Merk A, Subramaniam S.

Curr Opin Struct Biol. 2013 Apr;23(2):268-76. doi: 10.1016/j.sbi.2013.03.007. Epub 2013 Apr 18. Review.

PMID:
23602427
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HIV entry and envelope glycoprotein-mediated fusion.

Blumenthal R, Durell S, Viard M.

J Biol Chem. 2012 Nov 30;287(49):40841-9. doi: 10.1074/jbc.R112.406272. Epub 2012 Oct 5. Review.

PMID:
23043104
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

Julien JP, Lee PS, Wilson IA.

Immunol Rev. 2012 Nov;250(1):180-98. doi: 10.1111/imr.12005. Review.

PMID:
23046130
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.

Steckbeck JD, Kuhlmann AS, Montelaro RC.

J Gen Virol. 2013 Jan;94(Pt 1):1-19. doi: 10.1099/vir.0.046508-0. Epub 2012 Oct 17. Review.

PMID:
23079381
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Multiantibody strategies for HIV.

Hiatt A, Zeitlin L, Whaley KJ.

Clin Dev Immunol. 2013;2013:632893. doi: 10.1155/2013/632893. Epub 2013 Jun 6. Review.

PMID:
23840243
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HIV-1 fusion protein exerts complex immunosuppressive effects.

Ashkenazi A, Faingold O, Shai Y.

Trends Biochem Sci. 2013 Jul;38(7):345-9. doi: 10.1016/j.tibs.2013.04.003. Epub 2013 May 17. Review.

PMID:
23685134
[PubMed - indexed for MEDLINE]
17.

The humoral response to HIV-1: new insights, renewed focus.

Alter G, Moody MA.

J Infect Dis. 2010 Oct 15;202 Suppl 2:S315-22. doi: 10.1086/655654. Review.

PMID:
20846039
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

New paradigms for functional HIV-specific nonneutralizing antibodies.

Forthal D, Hope TJ, Alter G.

Curr Opin HIV AIDS. 2013 Sep;8(5):393-401. doi: 10.1097/COH.0b013e328363d486. Review.

PMID:
23924999
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Epitope target structures of Fc-mediated effector function during HIV-1 acquisition.

Lewis GK, Guan Y, Kamin-Lewis R, Sajadi M, Pazgier M, Devico AL.

Curr Opin HIV AIDS. 2014 May;9(3):263-70. doi: 10.1097/COH.0000000000000055. Review.

PMID:
24670318
[PubMed - indexed for MEDLINE]
20.

Dendrimers as potential therapeutic tools in HIV inhibition.

Peng J, Wu Z, Qi X, Chen Y, Li X.

Molecules. 2013 Jul 5;18(7):7912-29. doi: 10.3390/molecules18077912. Review.

PMID:
23884127
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk